Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet
Pressmeddelande

Successful user meeting in Madrid highlights ScandiDos' innovative solutions

Scandidos

ScandiDos, renowned for its advanced QA solutions in radiotherapy, recently participated in a well-attended user meeting in Spain. The event served as a platform for active discussions and knowledge exchange, with a particular focus on quality assurance for moving targets in radiotherapy. With inspiring speakers and an engaged participant base, the meeting highlighted the importance of innovative medical technology in advancing cancer patient care.

ScandiDos' user meeting was organized by the company's local distributor, Fimecorp International S.L., and targeted both existing and potential users of ScandiDos' QA solutions. The event brought together clinical experts and medical physicists from across the country to share insights and experiences with ScandiDos' groundbreaking measurement phantom, Delta4 Phantom+. Delta4 Phantom+ is ScandiDos' most sought-after product and is used in quality assurance of cancer treatments at over 800 cancer clinics worldwide.

With over 50 participants actively engaging in discussions and sharing their expertise, the user meeting provided an ideal forum for enriching understanding within the field. Held at Central Hospital De La Defensa Gómez Ulla, the meeting featured demonstrations of ScandiDos products in a clinical environment. Among other things, the hospital showcased its process for quality assurance of treatments for moving targets using Delta4 Phantom+ along with ScandiDos' motion platform, Delta4 Hexamotion. Quality assurance for moving targets is crucial as it ensures that radiotherapy treatments are accurate and effective even when the tumor moves due to the patient's breathing or movements, thereby reducing the risk of damage to surrounding tissues and improving treatment outcomes.

“The user meeting proved exceptionally valuable as clinicians actively shared insights and results. We are delighted with the positive feedback on our products and are grateful for the development suggestions we received. These requests will guide us in developing solutions to meet our customers' varying needs even better. Engaging with such a dedicated group of users was truly inspiring," says Gustaf Piehl, CEO of ScandiDos.

CONTACT


Gustaf Piehl, CEO, ScandiDos: investor@scandidos.com, +46 18-472 30 20
ScandiDos AB (publ), 556613-0927
Uppsala Science Park, 751 83 Uppsala

ABOUT SCANDIDOS


ScandiDos is an innovative forward-thinking company with groundbreaking software and hardware solutions for patient quality assurance in modern radiation therapy. Our Delta4 Family of products delivers a comprehensive QA solution, making the treatment process safe and efficient. We reinforce the confidence in radiotherapy clinics by providing professionals at the clinics with power and performance through independent QA.

The head office is in Uppsala Science Park, where product development is carried out. Sales are carried out by sales offices in the USA, Malaysia, and France, directly in the Nordic countries and through distributors in over 50 countries.

ScandiDos is listed on NASDAQ First North Stockholm with the ticker code SDOS. Certified adviser is Erik Penser Bank. Additional investor information can be found at Scandidos.com. Product information can be found on Delta4family.com

Attachments


Successful user meeting in Madrid highlights ScandiDos' innovative solutions

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.